Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, announced the 24-month clinical results for the DynamX™ Coronary Bioadaptor System recently at...
Royal Philips, a global leader in health technology, on March 12 announced health economic results from the “Define Flair” clinical trial comparing...